
GLP-1 Receptor Agonists: How a Diabetes Medicine Became a Multitasking Marvel
Scientists are finding that medicines called GLP-1 receptor agonists do much more than just control blood sugar. A new review suggests these treatments might also protect the heart and kidneys while helping people manage their weight. Doctors can now match these multitasking medicines to the specific needs of each patient.
















